Loading
Get Access
Subscribe
Throughout 2025, the Indian healthcare and pharmaceutical sectors were subjected to a high volume of cyberattacks. Analysis indicates that Trojans and file infectors were the most prevalent threats, targeting millions of endpoints across the industry. Additionally, ransomware campaigns caused significant operational disruptions, threatening the security of critical research and development information.
The targeting of these sectors suggests a strategic interest in intellectual property theft and the disruption of essential medical services. Compromised clinical trial data can invalidate years of research and lead to significant legal liabilities. Furthermore, the reliance on digital endpoints makes these organizations highly vulnerable to automated malware campaigns that can bypass traditional perimeter defenses.
Advisory purposes only · QPulse Security Intelligence Platform · 2026 · Brief #00417
